Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients

Tobias Deuse^#¹, Xiaomeng Hu^#^{1

2

3}, Alessia Gravina¹, Dong Wang^{1

2}, Grigol Tediashvili^{1

2

3}, Chandrav De⁴, William O Thayer⁴, Angela Wahl⁴, J Victor Garcia⁴, Hermann Reichenspurner^{2

3}, Mark M Davis⁵, Lewis L Lanier⁶, Sonja Schrepfer⁷

Affiliations

¹ Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology-Lab, University of California San Francisco, San Francisco, CA, USA.
² Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany.
³ Cardiovascular Research Center Hamburg and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
⁴ Division of Infectious Diseases, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
⁵ Howard Hughes Medical Institute, Institute for Immunity, Transplantation and Infection, and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
⁶ Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California San Francisco, San Francisco, California, USA.
⁷ Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology-Lab, University of California San Francisco, San Francisco, CA, USA. Sonja.Schrepfer@ucsf.edu.

^# Contributed equally.

Free article

Published Erratum

Tobias Deuse et al. Nat Biotechnol. 2022 Nov.

Free article

. 2022 Nov;40(11):1690.

doi: 10.1038/s41587-022-01426-8.

¹ Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology-Lab, University of California San Francisco, San Francisco, CA, USA.
² Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany.
³ Cardiovascular Research Center Hamburg and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
⁴ Division of Infectious Diseases, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
⁵ Howard Hughes Medical Institute, Institute for Immunity, Transplantation and Infection, and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
⁶ Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California San Francisco, San Francisco, California, USA.
⁷ Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology-Lab, University of California San Francisco, San Francisco, CA, USA. Sonja.Schrepfer@ucsf.edu.

^# Contributed equally.

No abstract available

Erratum for

Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
Deuse T, Hu X, Gravina A, Wang D, Tediashvili G, De C, Thayer WO, Wahl A, Garcia JV, Reichenspurner H, Davis MM, Lanier LL, Schrepfer S. Deuse T, et al. Nat Biotechnol. 2019 Mar;37(3):252-258. doi: 10.1038/s41587-019-0016-3. Epub 2019 Feb 18. Nat Biotechnol. 2019. PMID: 30778232 Free PMC article.